Moreover, the 36-month beta value for VINC is 1.10. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for VINC is 1.85M and currently, short sellers hold a 12.73% of that float. On February 05, 2025, VINC’s average trading volume was 718.02K shares.
VINC) stock’s latest price update
Vincerx Pharma Inc (NASDAQ: VINC)’s stock price has dropped by -11.18 in relation to previous closing price of 1.61. Nevertheless, the company has seen a loss of -13.33% in its stock price over the last five trading days. globenewswire.com reported 2025-01-23 that Vincerx’s Common Stock to Begin Trading on a Split-adjusted Basis on January 28, 2025 Vincerx’s Common Stock to Begin Trading on a Split-adjusted Basis on January 28, 2025
VINC’s Market Performance
Vincerx Pharma Inc (VINC) has seen a -13.33% fall in stock performance for the week, with a -69.61% decline in the past month and a -79.51% plunge in the past quarter. The volatility ratio for the week is 18.34%, and the volatility levels for the past 30 days are at 14.98% for VINC. The simple moving average for the past 20 days is -46.13% for VINC’s stock, with a -86.41% simple moving average for the past 200 days.
Analysts’ Opinion of VINC
Many brokerage firms have already submitted their reports for VINC stocks, with H.C. Wainwright repeating the rating for VINC by listing it as a “Buy.” The predicted price for VINC in the upcoming period, according to H.C. Wainwright is $25 based on the research report published on January 14, 2022 of the previous year 2022.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see VINC reach a price target of $25. The rating they have provided for VINC stocks is “Overweight” according to the report published on December 23rd, 2021.
SVB Leerink gave a rating of “Outperform” to VINC, setting the target price at $24 in the report published on November 01st of the previous year.
VINC Trading at -62.57% from the 50-Day Moving Average
After a stumble in the market that brought VINC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.24% of loss for the given period.
Volatility was left at 14.98%, however, over the last 30 days, the volatility rate increased by 18.34%, as shares sank -68.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -73.80% lower at present.
During the last 5 trading sessions, VINC fell by -13.33%, which changed the moving average for the period of 200-days by -92.48% in comparison to the 20-day moving average, which settled at $2.6543. In addition, Vincerx Pharma Inc saw -72.79% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for VINC
Current profitability levels for the company are sitting at:
- -21.44 for the present operating margin
- 0.4 for the gross margin
The net margin for Vincerx Pharma Inc stands at -20.57. The total capital return value is set at -2.96. Equity return is now at value -217.55, with -131.14 for asset returns.
Based on Vincerx Pharma Inc (VINC), the company’s capital structure generated 0.15 points at debt to capital in total, while cash flow to debt ratio is standing at -17.06. The debt to equity ratio resting at 0.18. The interest coverage ratio of the stock is -37.16.
Currently, EBITDA for the company is -42.61 million with net debt to EBITDA at 0.05. When we switch over and look at the enterprise to sales, we see a ratio of 1.45. The receivables turnover for the company is 1.24for trailing twelve months and the total asset turnover is 0.09. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.17.
Conclusion
To wrap up, the performance of Vincerx Pharma Inc (VINC) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
